Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
2022 · Signal Transduction and Targeted Therapy · 314 citations
https://doi.org/10.1038/s41392-022-01055-2
H
Hui Huang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
138
Papers
3.0K
Citations
29
h-index
55
i10-index
Hui Huang is an academic researcher from Agency for Science, Technology and Research. The author has contributed to research in topics: Parathyroid Disorders and Treatments & Heavy Metal Exposure and Toxicity & RNA modifications and cancer. The author has an h-index of 29, co-authored 118 publications.
ORCID: 0000-0001-5716-4012Papers by this author
worksInflammasomes as therapeutic targets in human diseases
2021 · Signal Transduction and Targeted Therapy · 212 citations
https://doi.org/10.1038/s41392-021-00650-z
Associations of multiple plasma metals with the risk of metabolic syndrome: A cross-sectional study in the mid-aged and older population of China
2022 · Ecotoxicology and Environmental Safety · 76 citations
https://doi.org/10.1016/j.ecoenv.2022.113183
Nanomaterial-based optical- and electrochemical-biosensors for urine glucose detection: A comprehensive review
2022 · Advanced Sensor and Energy Materials · 69 citations
https://doi.org/10.1016/j.asems.2022.100016
Ultrasensitive detection of clinical pathogens through a target-amplification-free collateral-cleavage-enhancing CRISPR-CasΦ tool
2025 · Nature Communications · 50 citations
https://doi.org/10.1038/s41467-025-59219-x
Tubular Mas receptor mediates lipid-induced kidney injury
2021 · Cell Death and Disease · 35 citations
https://doi.org/10.1038/s41419-020-03375-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat